CMF-03609 | SSPO | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-04227 | RBPJL | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-04466 | MYH8 | down-regulates | FEV | represses | R-3032 | 5 | 3 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-05638 | ITGB7 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-06077 | FGFR3 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-06113 | HTR5A | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-07203 | NELL1 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-10008 | ALB | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-11548 | PREX2 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-14620 | C1orf177 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-16748 | CPNE8 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-17304 | SYNJ2 | down-regulates | FEV | represses | R-3032 | 5 | 3 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-17384 | TBC1D8 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-17530 | CNTNAP3 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-18332 | DNMBP | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-19647 | RPSAP58 | down-regulates | FEV | represses | R-3032 | 5 | 4 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-19693 | UGT2B4 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-20119 | TDRD9 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-21895 | PRAME | down-regulates | FEV | represses | R-3032 | 5 | 3 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-24327 | SMCHD1 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-24382 | PREX1 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-24949 | NLRP1 | down-regulates | FEV | represses | R-3032 | 5 | 3 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-26584 | NAALADL1 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-27320 | CHD5 | down-regulates | FEV | represses | R-3032 | 5 | 4 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-27507 | KRTAP20-2 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-27609 | ANKRD36 | down-regulates | FEV | represses | R-3032 | 5 | 2 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |
CMF-31048 | PNPLA7 | down-regulates | FEV | represses | R-3032 | 5 | 1 | Drugs (18) Regulator Drugs (0)Regulon Drugs (18)FOSTAMATINIB DISODIUM, FIBOFLAPON SODIUM, R-343, AME-133V, R-348, CERDULATINIB, EFALIZUMAB, HMPL-523, ENTOSPLETINIB, R-333, GUSACITINIB, LIFITEGRAST, MIVAVOTINIB CITRATE, VELIFLAPON, FOSTAMATINIB, LANRAPLENIB, MIVAVOTINIB, FIBOFLAPON |